Acute respiratory distress syndrome (ARDS): from mechanistic insights to therapeutic strategies
MedComm · 2025-02 · 6 (2)
DOI: 10.1002/mco2.70074 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift MedComm, online erschienen am 26.01.2025. Verfasst von Rongli Xie und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery Ruijin Hospital Lu Wan Branch, Shanghai Jiaotong University School of Medicine Shanghai China. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 222 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Science and Technology Commission of Shanghai Municipality, Shanghai Municipal Health Commission.
Abstract (Originalsprache)
Acute respiratory distress syndrome (ARDS) is a clinical syndrome of acute hypoxic respiratory failure caused by diffuse lung inflammation and edema. ARDS can be precipitated by intrapulmonary factors or extrapulmonary factors, which can lead to severe hypoxemia. Patients suffering from ARDS have high mortality rates, including a 28‐day mortality rate of 34.8% and an overall in‐hospital mortality rate of 40.0%. The pathophysiology of ARDS is complex and involves the activation and dysregulation of multiple overlapping and interacting pathways of systemic inflammation and coagulation, including the respiratory system, circulatory system, and immune system. In general, the treatment of inflammatory injuries is a coordinated process that involves the downregulation of proinflammatory pathways and the upregulation of anti‐inflammatory pathways. Given the complexity of the underlying disease, treatment needs to be tailored to the problem. Hence, we discuss the pathogenesis and treatment methods of affected organs, including 2019 coronavirus disease (COVID‐19)‐related pneumonia, drowning, trauma, blood transfusion, severe acute pancreatitis, and sepsis. This review is intended to provide a new perspective concerning ARDS and offer novel insight into future therapeutic interventions.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of General Surgery Ruijin Hospital Lu Wan Branch, Shanghai Jiaotong University School of Medicine Shanghai China.
- Department of Urology Ruijin Hospital, Shanghai Jiaotong University School of Medicine Shanghai China.
- Department of General Surgery, Pancreatic Disease Center Ruijin Hospital, Shanghai Jiaotong University School of Medicine Shanghai China.
- Department of Emergency Ruijin Hospital, Shanghai Jiaotong University School of Medicine Shanghai China.
- Department of Radiology Södersjukhuset (Southern Hospital) Stockholm Sweden.
- Department of Molecular and Human Genetics Baylor College of Medicine Houston Texas USA.
ORCID-Profile: Rongli Xie
Förderung
- National Natural Science Foundation of China
- Science and Technology Commission of Shanghai Municipality
- Shanghai Municipal Health Commission
Zitieren
APA
Xie, R., Tan, D., Liu, B., Xiao, G., Gong, F., Zhang, Q., Qi, L., Zheng, S., Yuan, Y., Yang, Z., Chen, Y., Fei, J., & Xu, D. (2025). Acute respiratory distress syndrome (ARDS): from mechanistic insights to therapeutic strategies. MedComm, 6(2). https://doi.org/10.1002/mco2.70074
Vancouver
Xie R, Tan D, Liu B, Xiao G, Gong F, Zhang Q, et al. Acute respiratory distress syndrome (ARDS): from mechanistic insights to therapeutic strategies. MedComm. 2025;6(2). doi:10.1002/mco2.70074
BibTeX
@article{Xie2025,
author = {Xie, Rongli and Tan, Dan and Liu, Boke and Xiao, Guohui and Gong, Fangchen and Zhang, Qiyao and Qi, Lei and Zheng, Sisi and Yuan, Yuanyang and Yang, Zhitao and Chen, Ying and Fei, Jian and Xu, Dan},
title = {Acute respiratory distress syndrome (ARDS): from mechanistic insights to therapeutic strategies},
journal = {MedComm},
year = {2025},
volume = {6},
number = {2},
doi = {10.1002/mco2.70074}
}
EUVIMED